GENEVA, Aug. 6 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado BoulevardSuite 700Pasadena, California 91105) filed a patent application (PCT/US2025/012751) for "ANTI-TRANSFERRIN RECEPTOR ANTIBODIES, CONJUGATES THEREOF, AND USES THEREOF" on Jan 23, 2025. With publication no. WO/2025/160275, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GLEBOCKA, Agnieszka (Arrowhead Pharmaceuticals, Inc.502 S. Rosa RoadMADISON, Wisconsin 53719), XU, Zhao (Arrowhead Pharmaceuticals, Inc.10102 Hoyt Park DriveSan Diego, California 921...